Kynam Capital Management

Kynam Capital Management as of Sept. 30, 2023

Portfolio Holdings for Kynam Capital Management

Kynam Capital Management holds 28 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Natera (NTRA) 21.7 $133M 3.0M 44.25
Celldex Therapeutics Com New (CLDX) 14.4 $88M 3.2M 27.52
Vaxcyte (PCVX) 10.9 $66M 1.3M 50.98
Syndax Pharmaceuticals (SNDX) 9.5 $58M 4.0M 14.52
Vera Therapeutics Cl A (VERA) 6.6 $41M 3.0M 13.71
Protagonist Therapeutics (PTGX) 5.0 $30M 1.8M 16.68
2seventy Bio Common Stock (TSVT) 3.8 $23M 6.0M 3.92
Wave Life Sciences SHS (WVE) 3.7 $23M 3.9M 5.75
BioCryst Pharmaceuticals (BCRX) 3.6 $22M 3.1M 7.08
Cogent Biosciences (COGT) 3.5 $22M 2.2M 9.75
Liquidia Corporation Com New (LQDA) 2.1 $13M 2.0M 6.34
Acelyrin (SLRN) 2.0 $12M 1.2M 10.17
Amarin Corp Spons Adr New (AMRN) 1.8 $11M 12M 0.92
Miragen Therapeutics (VRDN) 1.8 $11M 700k 15.34
Taysha Gene Therapies Com Shs (TSHA) 1.7 $10M 3.3M 3.16
Travere Therapeutics (TVTX) 1.4 $8.7M 973k 8.94
Burning Rock Biotech Sponsored Ads (BNR) 1.3 $8.2M 8.5M 0.97
Dynavax Technologies Corp Com New (DVAX) 1.2 $7.4M 500k 14.77
Sutro Biopharma (STRO) 0.9 $5.4M 1.6M 3.47
Caribou Biosciences (CRBU) 0.8 $5.1M 1.1M 4.78
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.8 $4.7M 731k 6.47
Immunovant Put Option (IMVT) 0.6 $3.8M 100k 38.39
Olema Pharmaceuticals (OLMA) 0.5 $2.9M 235k 12.35
Puma Biotechnology (PBYI) 0.2 $1.2M 474k 2.63
Connect Biopharma Hldgs Ads (CNTB) 0.1 $434k 535k 0.81
Gossamer Bio (GOSS) 0.0 $208k 250k 0.83
Neoleukin Therapeutics Com New 0.0 $95k 24k 3.95
Catalyst Biosciences Com New 0.0 $43k 90k 0.48